Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Invasive Bladder Cancer Stage II”

195 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 195 results

Testing effectiveness (Phase 2)UnknownNCT04060459
What this trial is testing

Paclitaxel-binding Albumin and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Third Military Medical University 50
Testing effectiveness (Phase 2)Study completedNCT04383743
What this trial is testing

Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer

Who this might be right for
Stage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8Muscle Invasive Bladder Carcinoma
University of Washington 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT02845323
What this trial is testing

Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder

Who this might be right for
Urothelial CarcinomaBladder Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Testing effectiveness (Phase 2)Study completedNCT02177695
What this trial is testing

S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
SWOG Cancer Research Network 237
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05356351
What this trial is testing

An Open-label, Single-arm, Multicenter Phase II Clinical Study： Evaluating RC48-ADC Combined With Triplizumab in the Neoadjuvant Treatment of Her2-positive Muscle-invasive Bladder Cancer

Who this might be right for
Neoadjuvant Treatment of Her2-positive Muscle-invasive Bladder Cance
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06227065
What this trial is testing

Precise Neoadjuvant Chemoresection of Low Grade NMIBC

Who this might be right for
Bladder CancerNon-muscle Invasive Bladder CancerLow-risk
University of Bern 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT04375813
What this trial is testing

Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention

Who this might be right for
Non-muscle Invasive Bladder Cancer
Robert Svatek 166
Testing effectiveness (Phase 2)UnknownNCT02070120
What this trial is testing

Investigating Bladder Chemotherapy Instead of Surgery for Low Risk Bladder Cancer

Who this might be right for
Bladder Cancer
Institute of Cancer Research, United Kingdom 82
Testing effectiveness (Phase 2)Active Not RecruitingNCT02447549
What this trial is testing

Study of Tumour Focused Radiotherapy for Bladder Cancer

Who this might be right for
Bladder Cancer
Institute of Cancer Research, United Kingdom 345
Testing effectiveness (Phase 2)Looking for participantsNCT05644041
What this trial is testing

Intravesical Gem/Doce in Patients With NMIBC

Who this might be right for
Urinary Bladder Cancer
University of Arizona 25
Testing effectiveness (Phase 2)Study completedNCT02365818
What this trial is testing

Safety and Efficacy of CG0070 Oncolytic Virus Regimen for High Grade NMIBC After BCG Failure

Who this might be right for
Bladder Cancer
CG Oncology, Inc. 66
Testing effectiveness (Phase 2)Study completedNCT03212651
What this trial is testing

Study Evaluating Neoadjuvant Pembrolizumab Monotherapy in Patients With Muscle-Invasive Bladder Cancer to Explore in Vivo the Mechanisms of Action of Pembrolizumab

Who this might be right for
Bladder Cancer
Gustave Roussy, Cancer Campus, Grand Paris 41
Testing effectiveness (Phase 2)Study completedNCT00066612
What this trial is testing

S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
SWOG Cancer Research Network 45
Not applicableStudy completedNCT01224665
What this trial is testing

S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
SWOG Cancer Research Network 658
Testing effectiveness (Phase 2)Study completedNCT00005644
What this trial is testing

Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Eastern Cooperative Oncology Group
Large-scale testing (Phase 3)Active Not RecruitingNCT03775265
What this trial is testing

Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer

Who this might be right for
Bladder Urothelial CarcinomaMuscle Invasive Bladder CarcinomaStage II Bladder Cancer AJCC v8+1 more
National Cancer Institute (NCI) 475
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05996952
What this trial is testing

RC48-ADC in Adjuvant/Salvage Treatment of HER2 Positive Non-muscle-invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
West China Hospital 77
Testing effectiveness (Phase 2)Looking for participantsNCT07283835
What this trial is testing

Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin

Who this might be right for
Non Muscle Invasive Bladder CancerHigh-grade Ta/ T1 Papillary Disease Bladder Cancer
Lepu Biopharma Co., Ltd. 16
Testing effectiveness (Phase 2)UnknownNCT05297552
What this trial is testing

RC48-ADC Combined With JS001 For Perioperative Treatment of Muscle-Invasive Bladder Cancer

Who this might be right for
Muscle Invasive Bladder Carcinoma
RemeGen Co., Ltd. 40
Testing effectiveness (Phase 2)Looking for participantsNCT05327647
What this trial is testing

A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder Cancer
CHU de Quebec-Universite Laval 160
Load More Results